“Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19”, Journal of Pharmaceutical Negative Results, vol. 13, no. 2, pp. 82–86, Jun. 2022, Accessed: Jun. 09, 2026. [Online]. Available: https://mail.pnrjournal.com/index.php/home/article/view/199